Coombs, J. H., Bloom, B. J., Breedveld, F. C., Fletcher, M. P., Gruben, D., Kremer, J. M., Burgos-Vargas, R., Wilkinson, B., Zerbini, C. A. F., & Zwillich, S. H. (2010). improved pain, physical functioning and health status in patients with rheumatoid arthritis treated with CP-690, 550, an orally active Janus kinase (JAK) inhibitor: results from a randomised, double-blind, placebo-controlled trial. Annals of the rheumatic diseases, 69(2), 413–416. http://access.bl.uk/ark:/81055/vdc_100130162874.0x00005f